C. Thorball

发表

Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.

Michael C. McDaniel, A. Quyyumi, B. Gogas, 2015, Atherosclerosis.

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study

H. H. Klausen, O. Andersen, J. Eugen-Olsen, 2012, Critical Care.

Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment

V. Roth, J. Fellay, K. Metzner, 2019 .

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants

H. Ullum, L. Kessing, J. Eugen-Olsen, 2014, PloS one.

A polygenic risk score to predict sudden cardiac arrest in patients with coronary artery disease

Z. Kutalik, C. Redin, O. Muller, 2022, medRxiv.

Inflammatory Markers in the Second Trimester Prior to Clinical Onset of Preeclampsia, Intrauterine Growth Restriction, and Spontaneous Preterm Birth

S. Ladelund, J. Eugen-Olsen, C. Thorball, 2013, Inflammation.

Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia

A. Järvinen, C. Thorball, E. Ruotsalainen, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

HIV host genomics in the era of effective antiretroviral therapy

C. Thorball, 2020 .

Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death

A. Quyyumi, V. Vaccarino, S. Epstein, 2017, Circulation. Cardiovascular quality and outcomes.

Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events

A. Quyyumi, D. Kremastinos, N. Le, 2014, Journal of the American Heart Association.

Cannabis use and atherosclerotic cardiovascular disease: a Mendelian randomization study

Z. Kutalik, T. Schoeler, J. Vaucher, 2023, medRxiv.

Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment.

V. Roth, J. Fellay, K. Metzner, 2020, Journal of acquired immune deficiency syndromes.

Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model

J. Fellay, A. Telenti, N. Beerenwinkel, 2014, PLoS pathogens.

Associations of genetic and infectious risk factors with coronary heart disease

J. Fellay, P. Vollenweider, T. Waterboer, 2022, medRxiv.

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population

C. Pisinger, S. Ladelund, O. Andersen, 2014, Biomarker insights.

Inflammatory Markers in the Second Trimester Prior to Clinical Onset of Preeclampsia, Intrauterine Growth Restriction, and Spontaneous Preterm Birth

S. Ladelund, J. Eugen-Olsen, C. Thorball, 2013, Inflammation.

Increased CHIP Prevalence Amongst People Living with HIV

E. Boerwinkle, P. Libby, J. Fellay, 2020, medRxiv.